Xencor (XNCR) Preferred Shares (2013)
Xencor's (XNCR) quarterly Preferred Shares came in at $13.4 million in Q4 2013.
Xencor (XNCR) Preferred Shares (2013) Analysis & Trends
Xencor (XNCR) has 1 years of Preferred Shares data on file, last reported at $13.4 million in Q4 2013.
- On a quarterly basis, Preferred Shares changed N/A year-over-year to $13.4 million in Q4 2013; TTM through Dec 2013 was $13.4 million, a N/A change from a year earlier, with the FY2013 full-year figure at $13.4 million, changed N/A from the prior year.
- Preferred Shares for Q4 2013 stood at $13.4 million.
- Over the last five years, Preferred Shares for XNCR reached as high as $13.4 million in Q4 2013 and fell as low as $13.4 million in Q4 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 13.36 Mn |